What Does CVS Health (CVS) Resolve With Its $315 Million Opioid Settlement?

CVS Health (NYSE:CVS) agreed to a US$315 million settlement resolving allegations of improper opioid prescription dispensing. The accord concludes federal claims that CVS pharmacies filled opioid prescriptions that allegedly violated US controlled substances law. CVS Health committed to new controlled substance oversight measures as part of the settlement, including tighter monitoring of opioid dispensing. This opioid settlement and the fresh compliance obligations only capture one piece of...